Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward

Get the Details Now.

SNSE Insider Trading (Sensei Biotherapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $2,065,485.67

Insider Selling (Last 12 Months): $212,883.72

Sensei Biotherapeutics Insider Trading History Chart

Sensei Biotherapeutics Share Price & Price History

^$1.61

+0.30 (1.20%)

As of 05/19/2022 01:00 AM ET

Days: 30 | 90 | 365

Stock With Great Potential

From Wealthy Millionaire | Ad

Analyst says this stock could make quick strides with its unbelievable assets.

Learn more

Sensei Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/2/2022	James Peyer	Director	Buy	1,203	$3.20	$3,849.60
3/1/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	2,458	$3.60	$8,848.80
2/28/2022	James Peyer	Director	Buy	42	$3.60	$151.20
2/24/2022	James Peyer	Director	Buy	15,000	$3.63	$54,450.00
2/23/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	2,500	$3.80	$9,500.00
2/18/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	15,000	$3.97	$59,550.00
2/17/2022	James Peyer	Director	Buy	4,949	$4.17	$20,637.33
2/16/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	2,551	$4.25	$10,841.75
2/14/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	10,000	$4.18	$41,800.00
2/11/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	12,500	$4.40	$55,000.00
2/10/2022	James Peyer	Director	Buy	5,000	$4.58	$22,900.00
2/8/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	10,000	$4.33	$43,300.00
2/4/2022	James Peyer	Director	Buy	2,500	$4.45	$11,125.00
2/3/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	17,500	$4.65	$81,375.00
1/28/2022	James Peyer	Director	Buy	8,900	$4.22	$37,558.00
1/27/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	6,100	$4.31	$26,291.00
1/26/2022	James Peyer	Director	Buy	29,900	$4.62	$138,138.00
1/25/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	20,100	$4.86	$97,686.00
1/24/2022	James Peyer	Director	Buy	22,707	$4.69	$106,495.83
1/21/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	24,703	$4.94	$122,032.82
1/20/2022	James Peyer	Director	Buy	20,000	$5.17	$103,400.00
1/19/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	10,244	$4.97	$50,912.68
1/18/2022	James Peyer	Director	Buy	10,000	$5.08	$50,800.00
1/14/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	6,219	$4.99	$31,032.81
1/13/2022	James Peyer	Director	Buy	19,953	$5.13	$102,358.89
1/12/2022	Cambrian Biopharma Inc	Major Shareholder	Buy	9,202	$5.22	$48,034.44
1/11/2022	James Peyer	Director	Buy	10,845	$5.18	$56,177.10
12/29/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	69,000	$4.98	$343,620.00
12/28/2021	James Peyer	Director	Buy	11,288	$5.28	$59,600.64
12/27/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	3,712	$5.30	$19,673.60
12/23/2021	James Peyer	Director	Buy	11,000	$5.27	$57,970.00
12/17/2021	James Peyer	Director	Buy	117	$5.29	$618.93
12/16/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	10,925	$5.25	$57,356.25
12/9/2021	Thomas G. Ricks	Director	Buy	20,000	$6.62	$132,400.00
8/11/2021	Robert Hamilton Pierce	Insider	Sell	16,030	$7.34	$117,660.20
8/9/2021	Robert Hamilton Pierce	Insider	Sell	6,982	$7.06	$49,292.92
8/6/2021	Robert Hamilton Pierce	Insider	Sell	6,460	$7.11	$45,930.60
5/5/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	350	$12.00	$4,200.00
4/20/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	385	$12.77	$4,916.45
4/19/2021	James Peyer	Director	Buy	1,965	$13.38	$26,291.70
4/13/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	2,000	$14.00	$28,000.00
4/7/2021	James Peyer	Director	Buy	2,000	$14.00	$28,000.00
4/1/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	1,000	$14.00	$14,000.00
3/30/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	2,000	$12.00	$24,000.00
3/30/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	2,000	$12.00	$24,000.00
3/24/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	3,750	$14.12	$52,950.00
3/23/2021	James Peyer	Director	Buy	10,000	$14.34	$143,400.00
3/22/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	2,183	$15.02	$32,788.66
3/18/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	817	$15.25	$12,459.25
3/8/2021	James Peyer	Director	Buy	1,000	$15.25	$15,250.00
3/5/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	8,000	$13.75	$110,000.00
2/23/2021	James Peyer	Director	Buy	20,300	$17.79	$361,137.00
2/22/2021	Cambrian Biopharma Inc	Major Shareholder	Buy	9,802	$18.88	$185,061.76

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Sensei Biotherapeutics (NASDAQ:SNSE)

11.10% of Sensei Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sensei Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/17/2022	Jane Street Group LLC	10,767	$25K	0.0%	N/A	0.035%
5/16/2022	State Street Corp	225,572	$0.52M	0.0%	+7.3%	0.735%
5/16/2022	UBS Group AG	13,618	$31K	0.0%	-39.2%	0.044%
5/13/2022	Renaissance Technologies LLC	83,195	$0.19M	0.0%	N/A	0.271%
5/12/2022	BlackRock Inc.	1,168,011	$2.70M	0.0%	-2.9%	3.807%
5/12/2022	HighTower Advisors LLC	50,229	$0.12M	0.0%	N/A	0.164%
5/11/2022	Raymond James & Associates	13,000	$30K	0.0%	N/A	0.042%
5/3/2022	Leo Brokerage LLC	14,845	$34K	0.0%	N/A	0.048%
2/23/2022	BlackRock Inc.	1,202,729	$6.98M	0.0%	+20.2%	3.931%
2/19/2022	Wells Fargo & Company MN	8,783	$51K	0.0%	+14,298.4%	0.029%
2/17/2022	Goldman Sachs Group Inc.	11,098	$64K	0.0%	N/A	0.036%
2/17/2022	Virtu Financial LLC	15,980	$93K	0.0%	N/A	0.052%
2/15/2022	Millennium Management LLC	87,290	$0.51M	0.0%	-66.3%	0.285%
2/15/2022	Cubist Systematic Strategies LLC	12,804	$74K	0.0%	N/A	0.042%
2/14/2022	State Street Corp	210,292	$1.22M	0.0%	+25.2%	0.687%
2/14/2022	Goldman Sachs Group Inc.	11,098	$64K	0.0%	N/A	0.036%
2/14/2022	Nuveen Asset Management LLC	51,547	$0.27M	0.0%	-8.5%	0.168%
2/11/2022	Geode Capital Management LLC	256,518	$1.49M	0.0%	-6.4%	0.838%
2/11/2022	Charles Schwab Investment Management Inc.	43,865	$0.26M	0.0%	-5.8%	0.143%
2/10/2022	Rhumbline Advisers	18,894	$0.11M	0.0%	+14.0%	0.062%
2/10/2022	JPMorgan Chase & Co.	159,778	$0.93M	0.0%	-5.6%	0.522%
2/10/2022	Citigroup Inc.	6,421	$37K	0.0%	+166.5%	0.021%
2/8/2022	Bank of America Corp DE	25,034	$0.15M	0.0%	+194.0%	0.082%
11/19/2021	American International Group Inc.	11,437	$0.12M	0.0%	+168.1%	0.037%
11/18/2021	Bank of New York Mellon Corp	47,066	$0.50M	0.0%	+155.4%	0.154%
11/16/2021	Jane Street Group LLC	10,773	$0.11M	0.0%	N/A	0.035%
11/16/2021	Millennium Management LLC	258,659	$2.72M	0.0%	N/A	0.846%
11/16/2021	Moore Capital Management LP	49,341	$0.52M	0.0%	-61.3%	0.161%
11/16/2021	Citadel Advisors LLC	123,258	$1.30M	0.0%	-56.5%	0.403%
11/15/2021	Royal Bank of Canada	2,411	$25K	0.0%	+255.1%	0.008%
11/15/2021	Morgan Stanley	3,315	$35K	0.0%	-96.9%	0.011%
11/12/2021	Tao Capital Management LP	32,784	$0.35M	0.1%	N/A	0.107%
11/12/2021	The Manufacturers Life Insurance Company	13,478	$0.14M	0.0%	N/A	0.044%
11/12/2021	Geode Capital Management LLC	273,978	$2.88M	0.0%	+93.2%	0.896%
11/10/2021	Citigroup Inc.	2,409	$25K	0.0%	+565.5%	0.008%
11/9/2021	BlackRock Inc.	1,000,322	$10.52M	0.0%	+175.2%	3.270%
11/5/2021	Truist Financial Corp	70,374	$0.74M	0.0%	N/A	0.230%
11/4/2021	Deutsche Bank AG	12,021	$0.13M	0.0%	+158.3%	0.039%
11/1/2021	SG Americas Securities LLC	12,614	$0.13M	0.0%	N/A	0.041%
10/13/2021	BFT Financial Group LLC	14,845	$0.16M	0.0%	N/A	0.049%
8/23/2021	Morgan Stanley	107,726	$1.05M	0.0%	+1,538.4%	0.352%
8/17/2021	Wells Fargo & Company MN	11,081	$0.11M	0.0%	+365.6%	0.036%
8/17/2021	Citadel Advisors LLC	283,667	$2.77M	0.0%	-59.0%	0.927%
8/16/2021	Bank of America Corp DE	11,675	$0.12M	0.0%	-16.4%	0.038%
8/16/2021	Alyeska Investment Group L.P.	40,000	$0.39M	0.0%	N/A	0.131%
8/16/2021	Tudor Investment Corp Et Al	28,111	$0.27M	0.0%	-75.2%	0.092%
8/16/2021	Morgan Stanley	107,726	$1.05M	0.0%	+1,538.4%	0.352%
8/16/2021	Charles Schwab Investment Management Inc.	54,965	$0.54M	0.0%	+18.9%	0.180%
8/16/2021	State Street Corp	100,000	$0.98M	0.0%	+70.2%	0.327%
8/13/2021	Formula Growth Ltd.	100,000	$0.98M	0.1%	+77.7%	0.327%
8/13/2021	Northern Trust Corp	75,011	$0.73M	0.0%	-8.5%	0.245%
8/13/2021	Geode Capital Management LLC	141,809	$1.38M	0.0%	+20.8%	0.464%
8/13/2021	Vanguard Group Inc.	387,753	$3.78M	0.0%	+19.4%	1.268%
8/12/2021	JPMorgan Chase & Co.	179,078	$1.75M	0.0%	+15.1%	0.585%
8/11/2021	Bank of New York Mellon Corp	18,431	$0.18M	0.0%	+31.1%	0.060%
8/11/2021	BlackRock Inc.	363,466	$3.55M	0.0%	+9.2%	1.188%
8/11/2021	Deutsche Bank AG	4,653	$45K	0.0%	-73.3%	0.015%
8/2/2021	New York State Common Retirement Fund	5,396	$53K	0.0%	+37.2%	0.018%
5/27/2021	Davidson Kempner Capital Management LP	26,000	$0.38M	0.0%	N/A	0.085%
5/21/2021	Citadel Advisors LLC	692,537	$10.06M	0.0%	N/A	2.264%
5/18/2021	Zimmer Partners LP	46,000	$0.67M	0.0%	N/A	0.150%
5/18/2021	Morgan Stanley	6,575	$96K	0.0%	N/A	0.021%
5/18/2021	Tudor Investment Corp Et Al	113,353	$1.65M	0.0%	N/A	0.371%
5/18/2021	Duquesne Family Office LLC	100,000	$1.45M	0.0%	N/A	0.327%
5/18/2021	Davidson Kempner Capital Management LP	26,000	$0.38M	0.0%	N/A	0.085%
5/18/2021	Citadel Advisors LLC	692,537	$10.06M	0.0%	N/A	2.264%
5/18/2021	Falcon Edge Capital LP	213,658	$3.10M	0.2%	N/A	0.699%
5/18/2021	California State Teachers Retirement System	11,494	$0.17M	0.0%	N/A	0.038%
5/17/2021	Deerfield Management Company L.P. Series C	375,000	$5.45M	0.1%	N/A	1.226%
5/17/2021	Nuveen Asset Management LLC	12,340	$0.18M	0.0%	N/A	0.040%
5/13/2021	Bank of New York Mellon Corp	14,062	$0.21M	0.0%	N/A	0.046%
5/12/2021	Serengeti Asset Management LP	20,000	$0.29M	0.1%	N/A	0.065%
5/12/2021	Northern Trust Corp	81,947	$1.19M	0.0%	N/A	0.268%
5/12/2021	Geode Capital Management LLC	117,406	$1.71M	0.0%	N/A	0.384%
5/12/2021	Pura Vida Investments LLC	67,357	$0.94M	0.0%	N/A	0.220%
5/12/2021	JPMorgan Chase & Co.	155,647	$2.26M	0.0%	N/A	0.509%
5/12/2021	UBS Group AG	2,099	$31K	0.0%	N/A	0.007%
5/11/2021	New York State Common Retirement Fund	3,934	$57K	0.0%	N/A	0.013%
5/7/2021	BlackRock Inc.	332,700	$4.83M	0.0%	N/A	1.088%
5/7/2021	American International Group Inc.	4,441	$65K	0.0%	N/A	0.015%

Data available starting January 2016

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

Today's Range

Now: $1.61

$1.60

$1.65

50 Day Range

MA: $2.02

$1.49

$2.81

52 Week Range

Now: $1.61

$1.45

$15.12

Volume

80,535 shs

Average Volume

110,181 shs

Market Capitalization

$49.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of Sensei Biotherapeutics?: Sensei Biotherapeutics' top insider shareholders include:
Cambrian Biopharma Inc (Major Shareholder)
James Peyer (Director)
Robert Hamilton Pierce (Insider)
Thomas G Ricks (Director)
Learn More about top insider investors at Sensei Biotherapeutics.
Who are the major institutional investors of Sensei Biotherapeutics?: Sensei Biotherapeutics' top institutional shareholders include:
BlackRock Inc. — 3.81%
State Street Corp — 0.74%
Renaissance Technologies LLC — 0.27%
HighTower Advisors LLC — 0.16%
Leo Brokerage LLC — 0.05%
UBS Group AG — 0.04%
Learn More about top institutional investors of Sensei Biotherapeutics stock.
Which major investors are selling Sensei Biotherapeutics stock?: Within the last quarter, SNSE stock was sold by these institutional investors:
BlackRock Inc.
UBS Group AG
Which major investors are buying Sensei Biotherapeutics stock?: Within the previous quarter, SNSE stock was bought by institutional investors including:
Renaissance Technologies LLC
HighTower Advisors LLC
State Street Corp
Leo Brokerage LLC
Raymond James & Associates
Jane Street Group LLC
Within the last year, these company insiders have bought Sensei Biotherapeutics stock:
Cambrian Biopharma Inc (Major Shareholder)
James Peyer (Director)
Robert Hamilton Pierce (Insider)
Learn More investors buying Sensei Biotherapeutics stock.

The Secret to Financial Freedom (True Financial Independence!)

From Oxford Club | Ad

Mark your calendar now...Thursday, June 9, at 8 p.m. ET.

That's when Bill O'Reilly will press stock-picking legend Alexander Green to reveal - for the first time ever - the secret to obtaining truly life-changing wealth in America.

You're Invited to Join FREE - Discover the Secret to True Financial Independence!

>>>

SNSE Insider Trading (Sensei Biotherapeutics)

Sensei Biotherapeutics Insider Trading History Chart

Sensei Biotherapeutics Share Price & Price History

Sensei Biotherapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Sensei Biotherapeutics (NASDAQ:SNSE)

Institutional Buying and Selling by Quarter

Sensei Biotherapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Sensei Biotherapeutics?

Who are the major institutional investors of Sensei Biotherapeutics?

Which major investors are selling Sensei Biotherapeutics stock?

Which major investors are buying Sensei Biotherapeutics stock?